West Pharmaceutical Services, Inc. Share Price
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 267.56 USD | -1.83% |
|
-4.52% | -18.32% |
| Capitalization | 1.92TCr 1.64TCr 1.53TCr 1.44TCr 2.65TCr 1,74300Cr 2.9TCr 18TCr 6.94TCr 82TCr 7.22TCr 7.07TCr 2,99800Cr | P/E ratio 2025 * |
38.9x | P/E ratio 2026 * | 34.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.88TCr 1.6TCr 1.49TCr 1.41TCr 2.59TCr 1,70000Cr 2.83TCr 17TCr 6.76TCr 80TCr 7.04TCr 6.9TCr 2,92400Cr | EV / Sales 2025 * |
6.13x | EV / Sales 2026 * | 5.69x |
| Free-Float |
95.72% | Yield 2025 * |
0.31% | Yield 2026 * | 0.33% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -1.83% | ||
| 1 week | -4.52% | ||
| Current month | -3.50% | ||
| 1 month | -2.30% | ||
| 3 months | +5.55% | ||
| 6 months | +18.96% | ||
| Current year | -18.32% |
| 1 week | 263.38 |  | 281.12 |
| 1 month | 253.32 | | 285.54 |
| Current year | 187.43 | | 348.9 |
| 1 year | 187.43 | | 348.9 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 53.88 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 55 | 24/04/2015 |
Robert McMahon
DFI | Director of Finance/CFO | 56 | 04/08/2025 |
Quintin Lai
IRC | Investor Relations Contact | 58 | 11/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hofmann
BRD | Director/Board Member | 73 | 16/10/2007 |
Mark Buthman
BRD | Director/Board Member | 64 | 01/02/2011 |
Douglas Michels
BRD | Director/Board Member | 68 | 07/03/2011 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.02% | 26 M€ | +12.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.83% | -4.52% | -19.32% | +10.89% | 1.92TCr | |
| +1.77% | +0.30% | +10.19% | +14.59% | 22TCr | |
| +0.12% | -1.47% | +20.72% | +25.29% | 13TCr | |
| +0.44% | +1.87% | +49.06% | +106.94% | 6.71TCr | |
| +0.23% | +3.57% | -11.57% | -20.93% | 5.73TCr | |
| +1.79% | -0.02% | +16.59% | +73.21% | 5.19TCr | |
| -2.87% | +2.24% | -15.17% | -42.66% | 2.61TCr | |
| -0.28% | -4.36% | +16.35% | +29.27% | 2.47TCr | |
| -1.06% | -3.80% | +5.39% | -35.53% | 2.34TCr | |
| +0.63% | -2.38% | -25.57% | +15.71% | 2.19TCr | |
| Average | -0.50% | -0.86% | +4.67% | +17.68% | 6.38TCr | |
| Weighted average by Cap. | -0.71% | -0.11% | +11.86% | +24.34% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 306.46Cr 261.08Cr 243.87Cr 229.46Cr 422.44Cr 28TCr 461.5Cr 2.85TCr 1.1TCr 13TCr 1.15TCr 1.13TCr 48TCr | 325.97Cr 277.69Cr 259.39Cr 244.06Cr 449.32Cr 30TCr 490.87Cr 3.03TCr 1.17TCr 14TCr 1.22TCr 1.2TCr 51TCr |
| Net income | 50Cr 42Cr 40Cr 37Cr 69Cr 4.51TCr 75Cr 462.44Cr 179.38Cr 2.13TCr 186.81Cr 182.87Cr 7.76TCr | 56Cr 48Cr 45Cr 42Cr 78Cr 5.09TCr 85Cr 522.26Cr 202.58Cr 2.4TCr 210.97Cr 206.53Cr 8.76TCr |
| Net Debt | -48Cr -41Cr -38Cr -36Cr -66Cr -4.32TCr -72Cr -442.56Cr -171.67Cr -2.03TCr -178.78Cr -175.01Cr -7.42TCr | -69Cr -59Cr -55Cr -52Cr -95Cr -6.25TCr -103.96Cr -641.23Cr -248.73Cr -2.95TCr -259.03Cr -253.57Cr -11TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/25/12 | 267.56 $ | -1.83% | 8,39,179 |
| 11/25/11 | 272.54 $ | +2.09% | 6,88,206 |
| 10/25/10 | 266.96 $ | +0.33% | 6,83,912 |
| 09/25/09 | 266.07 $ | -1.12% | 5,13,011 |
| 08/25/08 | 269.08 $ | -3.98% | 6,60,526 |
Delayed Quote Nyse, December 13, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition